| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/28/2002 | US20020037884 Blend containing polyvinyl alcohol |
| 03/28/2002 | US20020037883 Topical mixture |
| 03/28/2002 | US20020037877 Pharmaceutical suspension compositions lacking a polymeric suspending agent |
| 03/28/2002 | US20020037863 Novel anthelmintic combinations |
| 03/28/2002 | US20020037858 Pharmaceutical compositions comprising moexipril magnesium |
| 03/28/2002 | US20020037842 Mucin containing ophthalmic preparation |
| 03/28/2002 | US20020037841 Blood disorders; drug in aqueous solution |
| 03/28/2002 | US20020037837 Microcapsules; active materials, water in oil emulsion |
| 03/28/2002 | US20020037828 Pretreatment sexual intercourse |
| 03/28/2002 | US20020037561 Method for producing arachidonic acid |
| 03/28/2002 | US20020037491 Oral transmucosal delivery |
| 03/28/2002 | US20020037340 Chewing gum containing an effective amount of an active medicament |
| 03/28/2002 | US20020037329 Biochemically balanced peritoneal dialysis solutions |
| 03/28/2002 | US20020037324 Aqueous solubility pharmaceutical formulations |
| 03/28/2002 | US20020037322 Composition comprising a crystallographically stable, amorphous cephalosporin and processes for the preparation thereof |
| 03/28/2002 | US20020037321 Instant water dissolvable encapsulate and process |
| 03/28/2002 | US20020037319 Drug preparations |
| 03/28/2002 | US20020037318 Using copolymer in pharmaceutical and cosmetic preparations |
| 03/28/2002 | US20020037317 Sustained release bolus for delivery of a beneficial substance such as nutrients or drugs to ruminant animals |
| 03/28/2002 | US20020037316 Phospholipid-based powders for drug delivery |
| 03/28/2002 | US20020037313 Sustained-release nalmefene preparations and method |
| 03/28/2002 | US20020037312 Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
| 03/28/2002 | US20020037311 Transdermal delivery of lasofoxifene |
| 03/28/2002 | US20020037309 Process for the preparation of polymer-based sustained release compositions |
| 03/28/2002 | US20020037308 Angiogenic material and uses thereof |
| 03/28/2002 | US20020037303 Obtaining oil bodies from a cell; washing oil bodies to obtain a washed oil body preparation; formulating washed oil bodies with thioredoxin or thioredoxin reductase into an emulsion |
| 03/28/2002 | US20020037300 Semi-solid delivery vehicle and pharmaceutical compositions |
| 03/28/2002 | US20020037297 For therapy and prophylaxis allergic rhinitis, vasomotoric rhinitis, conjunctivitis, cold, and flu |
| 03/28/2002 | US20020037295 Oral or intranasal vaccines using hydrophobic complexes having proteosomes and lipopolysaccharides |
| 03/28/2002 | US20020037290 Compositions comprising heat shock proteins or alpha(2) macroglobulin, antigenic molecules and saponins, and methods of use thereof |
| 03/28/2002 | US20020037272 Methods for treating burns on mammalian skin to reduce the risk of infection and to minimize fluid loss |
| 03/28/2002 | US20020037268 Antimicrobial sanitizing lotion with skin protection properties |
| 03/28/2002 | US20020037261 Sunscreen composition containing sol-gel microcapsules |
| 03/28/2002 | US20020037257 Crystalline; substantially smooth and having a BET value from 1 to 4.5 m2/g; treatment of respiratory disorders by administration |
| 03/28/2002 | US20020036244 Method and apparatus for shaping particles by ultrasonic cavitation |
| 03/28/2002 | US20020036154 Solid pharmaceutical dosage formulation of hydrophobic drugs |
| 03/28/2002 | US20020035993 Highly efficient delivery of a large therapeutic mass aerosol |
| 03/28/2002 | US20020035992 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
| 03/28/2002 | DE19942424A1 Agent for maintenance of normal bowel activity and defecation comprises a material structured to provide release of incorporated active substance in the intestine |
| 03/28/2002 | DE10139115A1 Citalopram enthaltende pharmazeutische Zusammensetzung Citalopram pharmaceutical composition containing |
| 03/28/2002 | DE10046541A1 Oral dosage form useful as nutritional supplement or medicament comprises solid dispersion of ubiquinone in thermoplastic matrix |
| 03/28/2002 | DE10043457A1 Verfahren zur Behandlung von Schizophrenie und verwandten Psychosen sowie Verwendung von Erythropoietin oder Erythropoietinderivaten zur Behandlung von Schizophrenien und verwandten Psychosen A method for the treatment of schizophrenia and related psychoses, and the use of erythropoietin for the treatment or Erythropoietinderivaten of schizophrenia and related psychoses |
| 03/28/2002 | DE10043321A1 Transdermales therapeutisches System Transdermal therapeutic system |
| 03/28/2002 | DE10043011A1 New stabilized liposomes with stable internal skeleton derived from interfacial polymers, useful for enclosing and transporting pharmaceuticals or as micro-reactors for carrying out enzymatic reactions |
| 03/28/2002 | DE10042412A1 Transdermal patch for administering venlafaxin, useful for prophylaxis or therapy of psychoses, especially depression, as well as anxiety, neuroses and psychopathies |
| 03/28/2002 | DE10042411A1 Transdermales therapeutisches System zur Abgabe von Exemestan Transdermal therapeutic system for the delivery of exemestane |
| 03/28/2002 | CA2824077A1 Oral preparations with favorable disintegration characteristics |
| 03/28/2002 | CA2423329A1 Solid preparations |
| 03/28/2002 | CA2423172A1 Sustained release composition containing clarithromycin |
| 03/28/2002 | CA2423170A1 Pharmaceutical semi-solid composition of isotretinoin |
| 03/28/2002 | CA2422983A1 Methods for treating various eye disorders |
| 03/28/2002 | CA2422686A1 Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment |
| 03/28/2002 | CA2422215A1 B7-like molecules and uses thereof |
| 03/28/2002 | CA2421798A1 Ultrasonic method and device for wound treatment |
| 03/28/2002 | CA2419434A1 Medicinal composition |
| 03/28/2002 | CA2407465A1 Method of blocking free radical processes which result in mediated pathology without deleterious pro-oxidant side reactions |
| 03/27/2002 | EP1191098A2 Pharmaceutical composition for treatment of duchenne muscular dystrophy |
| 03/27/2002 | EP1190726A2 Liquefied embolic materials capable of sol-gel phase transition and their use |
| 03/27/2002 | EP1190721A2 A method for the anhydrous loading of nicotine onto ion exchange resins |
| 03/27/2002 | EP1190720A1 Liquid pharmaceutical composition for oral administration of bitter hydrolysis-susceptible active substances |
| 03/27/2002 | EP1190718A2 Ophthalmic compositions comprising amino alcohols |
| 03/27/2002 | EP1190712A1 Oral once daily tramadol beads composition |
| 03/27/2002 | EP1190707A1 High penetration transdermal medicament |
| 03/27/2002 | EP1190706A1 Liposomes |
| 03/27/2002 | EP1190705A1 Method of regulating leakage of drug encapsulated in liposomes |
| 03/27/2002 | EP1190255A1 Epitopes formed by non-covalent association of conjugates |
| 03/27/2002 | EP1190123A1 Encapsulation of crystals via multilayer coatings |
| 03/27/2002 | EP1190101A1 Compositions and methods for preventing transepithelial transmission of hiv |
| 03/27/2002 | EP1189926A2 Rapid dehydration of proteins |
| 03/27/2002 | EP1189749A1 Composite laminate and method for its production |
| 03/27/2002 | EP1189690A1 Method for production of microcapsules |
| 03/27/2002 | EP1189688A1 W/o type emulsions with a high water content containing medium polar lipids |
| 03/27/2002 | EP1189640A1 Pharmaceutical complex |
| 03/27/2002 | EP1189639A1 Filler binder for tablets |
| 03/27/2002 | EP1189620A1 Formulation comprising testosteron undecanoate and castor oil |
| 03/27/2002 | EP1189616A2 S-hydroxynefazodone |
| 03/27/2002 | EP1189614A2 Solid preparations containing paroxetine |
| 03/27/2002 | EP1189608A1 Levodopa/carbidopa/entacapone pharmaceutical preparation |
| 03/27/2002 | EP1189605A2 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof |
| 03/27/2002 | EP1189602A1 Morphine sulphate microgranules, method for preparing same and compositions containing same |
| 03/27/2002 | EP1189601A2 Delayed total release two pulse gastrointestinal drug delivery system |
| 03/27/2002 | EP1189600A1 Grf-containing lyophilized pharmaceutical compositions |
| 03/27/2002 | EP1189599A2 Pharmaceutical materials and methods for their preparation and use |
| 03/27/2002 | EP1189598A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 03/27/2002 | EP1189597A1 Oil-core compositions for the sustained release of hydrophobic drugs |
| 03/27/2002 | EP1189596A1 Pharmaceutical composition for nasally administering water-soluble active substances |
| 03/27/2002 | EP1189595A1 Ophthalmic compositions in form of aqueous gels |
| 03/27/2002 | EP1189589A1 Aqueous carrier systems for water-insoluble aromatic polymers |
| 03/27/2002 | EP1189587A1 Cosmetic or dermatological product comprising a freeze-dried hydrocolloid composition |
| 03/27/2002 | EP1189579A1 Gelled aqueous cosmetic compositions |
| 03/27/2002 | EP1189522A1 Use of nanoscale sterols and sterol esters |
| 03/27/2002 | EP0998501B1 Cationic polymers, complexes associating said cationic polymers with therapeutically active substances comprising at least a negative charge, in particular nucleic acids, and their use in gene therapy |
| 03/27/2002 | EP0961611B1 Expandable gastro-retentive therapeutic system with controlled active substance release in the gastro-intestinal tract |
| 03/27/2002 | EP0957931B1 Solid pharmaceutical compositions comprising a cyclosporin and an anionic surfactant |
| 03/27/2002 | EP0862915B1 Antibacterial composition for oral administration |
| 03/27/2002 | EP0844001B1 O/w emulsion composition for eye drops |
| 03/27/2002 | EP0837673B1 Polymeric lamellar substrate particles for drug delivery |
| 03/27/2002 | EP0828516B1 Skin permeation enhancer compositions using acyl lactylates |
| 03/27/2002 | EP0782448B1 Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions |
| 03/27/2002 | EP0639067B1 Use of perfluorcarbons for the preparation of potentiators of the ultrasound induced hyperthermia treatment of biological tissues |